Table 1

Baseline characteristics for 16 enrolled patients

Baseline characteristicValue
Median age, y (range)66 (31-81)
Sex, n, male/female6/10
Race, n
    White13
    Black0
    Hispanic or Latino1
    Asian1
    Other1
Median duration of ITP, y (range)9 (1 to ≥ 29)
Comorbidities
    n, median3
    At least 3 comorbidities, n (%)8 (50)
    History of ≥ 3 prior treatments, n (%)15 (94)
Prior treatments, n (%)
    Steroids16 (100)
    IVIg15 (94)
    Rituximab14 (88)
    Splenectomy11 (69)
    Anti-D9 (56)
    Danazol8 (50)
    Azathioprine6 (38)
    Thrombopoietic agents5 (31)
    Vincristine5 (31)
    GMA1613 (19)
    Anti-CD40L2 (13)
    Helicobacter pylori1 (6)
Median baseline platelet count, n × 109/L, (range)16 (2-28)
  • Baseline platelet count is defined as lowest count within 1 month of starting treatment. The most common comorbidities included hypertension (n = 5), dyslipidemia (n = 3), arthritis (n = 3), and diabetes (n = 3).